Psychometric properties of the itch numeric rating scale in patients with moderate to severe plaque psoriasis using data from a randomized clinical trial

被引：0
|
作者：
Naegli, April [1 ]
Zhu, Baojin [1 ]
Gaich, Carol [1 ]
Heredia, Emily [1 ]
Song, Grace [2 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Macrostat, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2014年 / 70卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P8729
引用
收藏
页码：AB181 / AB181
页数：1
相关论文
共 50 条
  • [41] Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis
    Viswanathan, Hema N.
    Mutebi, Alex
    Milmont, Cassandra E.
    Gordon, Kenneth
    Wilson, Hilary
    Zhang, Hao
    Klekotka, Paul A.
    Revicki, Dennis A.
    Augustin, Matthias
    Kricorian, Gregory
    Nirula, Ajay
    Strober, Bruce
    VALUE IN HEALTH, 2017, 20 (08) : 1174 - 1179
  • [42] Early onset of clinical improvement with ixekizumab in patients with moderate-to-severe plaque psoriasis
    Khatri, S.
    Amir, Y.
    Min, M.
    Goldblum, O.
    Solotkin, K.
    Yang, F.
    Ridenour, T.
    Lebwohl, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 73 - 74
  • [43] Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial
    Papp, KA
    Bressinck, R
    Fretzin, S
    Goffe, B
    Kempers, S
    Gordon, KB
    Caro, I
    Walicke, PA
    Wang, XL
    Menter, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (05) : 605 - 614
  • [44] Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: A phase 3 randomized trial
    Bissonnette, R.
    Iversen, L.
    Sofen, H.
    Griffiths, C. E. M.
    Foley, P.
    Romiti, R.
    Bachinsky, M.
    Rottinghaus, S. T.
    Tan, H.
    Proulx, J.
    Valdez, H.
    Gupta, P.
    Mallbris, L.
    Wolk, R.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 37 - 37
  • [45] Application of the Itch Severity Score in patients with moderate-to-severe plaque psoriasis: Clinically important difference and responder analyses
    Mamolo, Carla M.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (02) : 121 - 123
  • [46] Bimekizumab efficacy in patients with moderate to severe plaque psoriasis during the randomized withdrawal and retreatment phase of BE READY, a phase 3 trial
    Blauvelt, Andrew
    Wu, Jashin J.
    Reich, Kristian
    Gooderham, Melinda
    Lebwohl, Mark
    White, Katy
    Cross, Nancy
    Cioffi, Christopher
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB139 - AB139
  • [47] Secukinumab efficacy in patients with moderate to severe plaque psoriasis and psoriatic arthritis: A phase II, double-blind, randomized trial
    Gottlieb, Alice B.
    Guettner, Achim
    Papavassilis, Charis
    Helliwell, Philip
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB212 - AB212
  • [48] POPULATION PHARMACOKINETICS OF RISANKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: ANALYSES INCLUDING THE DATA FROM PHASE III CLINICAL TRIALS.
    Suleiman, A. A.
    Khatri, A.
    Minocha, M.
    Othman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S44 - S44
  • [49] Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
    Strober, Bruce
    Zhao, Yang
    Tran, Mary Helen
    Gnanasakthy, Ari
    Nyirady, Judit
    Papavassilis, Charis
    Nelson, Lauren M.
    McLeod, Lori D.
    Mordin, Margaret
    Gottlieb, Alice B.
    Elewski, Boni E.
    Lebwohl, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (03) : E147 - E155
  • [50] Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)
    Paul, C.
    Puig, L.
    Kragballe, K.
    Luger, T.
    Lambert, J.
    Chimenti, S.
    Girolomoni, G.
    Nicolas, J. -F.
    Rizova, E.
    Lavie, F.
    Mistry, S.
    Bergmans, P.
    Barker, J.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) : 425 - 434
12345